Results 111 to 120 of about 18,980 (173)
Molecular and cellular composition changes after neoadjuvant letrozole and palbociclib in early luminal breast cancer. [PDF]
Cell Rep MedCottu P, Kieffer Y, Lemonnier J, D'hondt V, Duhoux FP, Callens C, Gentien D, Reyes C, Boulai A, Desmoulins I, Mouret-Reynier MA, Levy C, Heudel PE, Dalenc F, Grenier J, Fuhrmann L, Baulande S, Delaloge S, Mechta-Grigoriou F, Vincent-Salomon A. +19 moreeuropepmc +1 more sourceReal-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC. [PDF]
ESMO OpenGirard N, Bar J, Baas P, Chouaid C, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido Lopez P, Gregorc V, Haakensen VD, Hiltermann TJN, Kao S, McDonald F, Mornex F, Moskovitz M, Peters S, Siva S, Solomon B, Qiao Y, Anand S, Chander P, Shcherbakova T, Diaz Perez I, Filippi AR. +24 moreeuropepmc +1 more sourcePre-synthetic redox control of structure and properties in copper TTFtt coordination polymers. [PDF]
Chem SciJiang N, Velliyarat S, Lien CY, Nguyen HL, Hofmann J, Chen JH, Ramanathan A, Filatov AS, La Pierre HS, Patel S, Chapman KW, Boyn JN, Anderson JS. +12 moreeuropepmc +1 more sourceA founder BRCA1 exonic duplication involving breakpoint in T2T reference genome-specific region results in constitutional fusion transcript. [PDF]
NPJ Genom MedSchwartz M, Filser M, Merchadou K, Lemaitre E, Abidallah K, Tenreiro H, Dubois D'enghien C, Rapinat A, Pierre-Noel E, Suybeng V, Espenel M, Baulande S, Adams S, Remenieras A, Renaud C, Aucouturier C, Delnatte C, Garrec C, Renault V, Golmard L, Fourme E, Masliah-Planchon J, Caputo SM. +22 moreeuropepmc +1 more sourceSurrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma. [PDF]
ESMO OpenShitara K, Bang YJ, Wyrwicz LS, Rha SY, Oshima T, Pietrantonio F, Park YK, Lonardi S, Yañez P, Yen CJ, Metges JP, Garrido M, Moehler M, Pelles-Avraham S, Yong WP, Spallanzani A, Jensen E, Krishnan R, Shih CS, Al-Batran SE. +19 moreeuropepmc +1 more sourceAdjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw OpenLeachman SA, Luke JJ, Ascierto PA, Long GV, Khattak MA, Rutkowski P, Xu ZJ, Fukunaga-Kalabis M, Krepler C, Eggermont AMM, Schadendorf D. +10 moreeuropepmc +1 more sourcePatient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial. [PDF]
ESMO OpenCurigliano G, O'Shaughnessy J, Bidard FC, Casalnuovo ML, Kim SB, Tokunaga E, Aftimos P, Saura C, Carey LA, Okera M, Melo E, Zagouri F, Magallanes-Maciel M, Karadurmus N, Bahadur S, Speck RM, Wang XA, Pradhan K, Macey J, Kitchen H, Fairhurst S, Miller J, Jhaveri KL, Harbeck N. +23 moreeuropepmc +1 more sourceCombining Population Genomics With Ancient DNA to Understand Island Colonisation History of the Madagascar Turtle Dove. [PDF]
Mol EcolDwivedi N, Heighton SP, Laso-Jadart R, Verry AJF, Nieto-Heredia A, Lesturgie P, Khost DE, Bohec M, Sackton TB, Chikhi L, Orlando L, Hume JP, Achaz G, Thèves C, Mona S, Warren BH. +15 moreeuropepmc +1 more source